High throughput screening assay of α1G T-type Ca 2+ channels and comparison with patch-clamp studies

Combinatorial Chemistry and High Throughput Screening

Volumn 12, Issue 3, 2009, Pages 296-302

  Kim, Yoonjee ^a,b   Kang, Soonja ^b   Lee, Jae Yeol ^c   Rhim, Hyewhon ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Ewha Womans University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4(3H) QUINAZOLINONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; CALCIUM CHANNEL T TYPE ALPHA 1G; CALCIUM ION; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; KYS 05034; KYS 05041; KYS 05042; KYS 05043; KYS 05044; KYS 05045; KYS 05046; KYS 05064; KYS 05065; MIBEFRADIL; NICKEL; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG; CALCIUM; FURA 2;

ARTICLE; CELL CULTURE; CELL STRAIN HEK293; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG TARGETING; FUNCTIONAL DRUG SCREENING SYSTEM 6000; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; PATCH CLAMP; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY ANALYSIS; CELL LINE; DRUG EFFECT; DRUG SCREENING; FLUOROMETRY; METHODOLOGY; STANDARD;

CALCIUM; CALCIUM CHANNELS, T-TYPE; CELL LINE; DRUG EVALUATION, PRECLINICAL; FLUOROMETRY; FURA-2; HUMANS; PATCH-CLAMP TECHNIQUES;

EID: 65549130987     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620709787581710     Document Type: Article

References (24)

1. Kim, T.; Choi, J.; Kim, S.; Kwon, O.; Nah, S. Y.; Han, Y. S.; Rhim, H. Biochem. Biophys. Res. Commun., 2004, 24, 401-408.
2. Ghosh A.; Greenberg, M. E. Science, 1995, 268, 239-247.
3. Berridge, M. J. Neuron, 1998, 21, 13-26.
4. Catterall, W. A. Annu. Rev. Cell Dev. Biol., 2000, 16, 521-555.
5. Hess, P. Annu. Rev. Neurosci., 1990, 13, 337-356.
6. Tsien, R. W.; Ellinor, P. T.; Horne, W. A. Trends Pharmacol. Sci., 1991, 12, 349-354.
7. Huguenard, J. R. Annu. Rev. Physiol., 1996, 58, 329-348.
8. Perez-Reyes, E. Physiol. Rev., 2003, 83, 117-161.
9. Zhou, Z.; Lipsius, S. L. J. Mol. Cell Cardiol., 1994, 26, 1211-1219.
10. Rossier, M. F.; Burnay, M. M.; Vallotton, M. B.; Capponi, A. M. Endocrinology, 1996, 137, 4817-4826.
11. Arnoult, C.; Cardullo, R. A.; Lemos, J. R.; Florman, H. M. Proc. Natl. Acad. Sci. USA, 1996, 93, 13004-13009.
12. Hughes, S. W.; Cope, D. W.; Blethyn, K. L.; Crunelli, V. Neuron, 2002, 33, 947-958.
13. Kim, D.; Park, D.; Choi, S.; Lee, S.; Sun, M.; Kim, C.; Shin, H. S. Science, 2003, 302, 117-119.
14. Choi, S.; Na, H. S.; Kim, J.; Lee, J.; Lee, S.; Kim, D.; Park, J.; Chen, C. C.; Campbell, K. P.; Shin, H.S. Genes Brain Behav., 2007, 6, 425-431.
15. McGivern, J.G. CNS Neurol. Disord. Drug Targets, 2006, 5, 587-603.
16. Shin, H. S.; Cheong, E. J.; Choi, S.; Lee, J.; Na, H.S. Curr. Opin. Pharmacol., 2008, 8, 33-41.
17. Liu, J. H.; Bijlenga, P.; Occhiodoro, T.; Fischer-Lougheed, J.; Bader, C. R.; Bernheim, L. Br. J. Pharmacol., 1999, 126, 245-250.
18. Krayenbuhl, J. C.; Vozeh, S.; Kondo-Oestreicher, M.; Dayer, P. Eur. J. Clin. Pharmacol., 1999, 55, 559-565.
19. Monteil, A.; Chemin, J.; Bourinet, E.; Mennessier, G.; Lory, P.; Nargeot, J. J. Biol. Chem., 2000, 275, 6090-6100.
20. Zhang, J. H.; Chung, T. D.; Oldenburg, K. R. J. Biomol. Screen., 1999, 4, 67-73.
21. McGivern, J.G. Drug Discov. Today, 2006, 11, 245-253.
22. Miljanich, G.P. Curr. Med. Chem., 2004, 11, 3029-3040.
23. Bourinet, E.; Alloui, A.; Monteil, A.; BarrÈre, C.; Couette, B.; Poirot, O.; Pages, A.; McRory, J.; Snutch, T. P.; Eschalier, A.; Nargeot, J. EMBO J., 2005, 24, 315-324.
24. Eglen, R. M.; Bosse, R.; Reisine, T. Assay Drug Dev. Technol., 2007, 5, 425-451.